Difficulty: Medium
Average Score: 90%
Practice
Which of the following drugs is incorrectly paired with its mechanism of action:
Correct answer
C
Rationale
In this question, the correct answer is option C: Gemfibrozil, which is incorrectly paired with its mechanism of action. Gemfibrozil is a fibric acid derivative that works by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha), leading to an increase in lipoprotein lipase activity, not inhibition. This activation of lipoprotein lipase results in decreased levels of very low-density lipoprotein (VLDL) and triglycerides.
Option A, Cholestyramine, is correctly paired with its mechanism of action as it binds bile acids in the intestine, leading to their excretion and thus decreasing cholesterol levels.
Option B, Ezetimibe, is also correctly paired with its mechanism of action as it inhibits the NPC1L1 transporter in the intestine, thereby reducing the absorption of dietary cholesterol.
Option D, Niacin, is incorrectly paired with its mechanism of action in this context. Niacin works by inhibiting hormone-sensitive lipase in adipose tissue, not lipoprotein lipase. This inhibition leads to reduced free fatty acid mobilization and decreased triglyceride synthesis.
In an educational context, understanding the mechanisms of action of cardiovascular drugs is crucial for healthcare professionals to make informed decisions in managing patients with cardiovascular diseases. Knowing the correct mechanisms of action helps in selecting the most appropriate treatment options and predicting possible drug interactions or side effects. Therefore, mastering pharmacology concepts like these ensures safe and effective patient care.
Option A, Cholestyramine, is correctly paired with its mechanism of action as it binds bile acids in the intestine, leading to their excretion and thus decreasing cholesterol levels.
Option B, Ezetimibe, is also correctly paired with its mechanism of action as it inhibits the NPC1L1 transporter in the intestine, thereby reducing the absorption of dietary cholesterol.
Option D, Niacin, is incorrectly paired with its mechanism of action in this context. Niacin works by inhibiting hormone-sensitive lipase in adipose tissue, not lipoprotein lipase. This inhibition leads to reduced free fatty acid mobilization and decreased triglyceride synthesis.
In an educational context, understanding the mechanisms of action of cardiovascular drugs is crucial for healthcare professionals to make informed decisions in managing patients with cardiovascular diseases. Knowing the correct mechanisms of action helps in selecting the most appropriate treatment options and predicting possible drug interactions or side effects. Therefore, mastering pharmacology concepts like these ensures safe and effective patient care.